The use of advanced genetic and molecular techniques, coupled with the generation of more sophisticated mouse models, will undoubtedly facilitate the exploration of AMPK in disease to create tailored therapeutic strategies and interventions for combating the rising tide of metabolic disorders to improve human health. This evidence concerns the gene PRKAA2 and metabolic disease.